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Top-down systems biology identifies molecular interaction networks in health and disease
using  system-wide  data  generated  by  high-throughput  –omics  technologies.  The  rapid
advances in  the post-genomic analytical  technologies,  most  notably  Mass  Spectrometry
(MS), has made possible to simultaneously analyze hundreds to thousands of metabolites in
biological fluids and intact tissues at a relatively low cost. The ability to generate, model,
and interpret such metabolic data in relation to benchmark patient clinical information,
enabled by powerful  bioinformatics  platforms,  makes  personalized medicine a  tangible
proposition.  The  advancements  in  the  field  of  metabolic  phenotyping  have  focused
primarily on instrument development and validation of the MS technologies. 
However, despite the significant advances in these areas, the major barrier to its wider
adoption and transition into main stream medicine and industry has been the challenge of
interpreting  and  managing  the  huge  data  sets  MS  generates.  The  interpretation  of
metabolic  data  is  dependent  on  the  advances  made  by  reconstruction  of  molecular
networks via cellular bottom-up systems biology models. 
This presentation outlines innovative bioinformatics solutions for emerging technologies of
mass  spectrometry  imaging  (MSI)  and  rapid  evaporative  ionization  mass  spectrometry
(REIMS),  targeting  unmet  medical  needs  of  cancer  network-driven  diagnosis  and  rapid
pathogen identification in sepsis. The translational bioinformatics platforms are presented
that allow intuitive clinically-oriented interrogation of MS datasets in an integrated and
streamlined  fashion.  These  developments  aim  to  overcome  current  methodological
roadblocks for effective clinical translation of MS technologies since the existing workflows
for data processing rely on a heterogeneous array of bioinformatic packages which are
poorly optimized and only suitable for specialists in the field [1], [2].
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